Medical expert of the article
New publications
Cholera prevention
Last reviewed: 04.07.2025
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
The basis of cholera prevention is a system of measures aimed at preventing the introduction of infection from endemic foci. Of great importance are the identification of patients and vibrio carriers, their timely isolation and sanitation from the pathogen. Localization and elimination of the infection focus presuppose a system of quarantine measures, including isolation and examination of persons who have been in contact with the patient, and provisional hospitalization of all those suffering from diarrheal diseases in the infection focus.
To create active immunity, a cholera vaccine is used - a bivalent chemical tablet cholera vaccine, which is a mixture of choleragen-anatoxin of broth cultures of Inaba and Ogawa cholera vibrios. Vaccination is carried out according to epidemiological indications. Vaccine dose:
- for children 2-10 years old - 1 tablet,
- for teenagers 11-17 years old - 2 tablets,
- For adults - 3 tablets once 1 hour before meals. Revaccination is carried out 6-7 months after the primary vaccination.
[